Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation

Prevention and treatment of myopia is an important public problem worldwide. We found a higher incidence of myopia among patients with inflammatory diseases such as type 1 diabetes mellitus (7.9%), uveitis (3.7%), or systemic lupus erythematosus (3.5%) compared to those without inflammatory diseases...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EBioMedicine 2016-08, Vol.10 (C), p.269-281
Hauptverfasser:	Lin, Hui-Ju, Wei, Chang-Ching, Chang, Ching-Yao, Chen, Ter-Hsin, Hsu, Yu-An, Hsieh, Yi-Ching, Chen, Hsuan-Ju, Wan, Lei
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Animals Anti-Inflammatory Agents - therapeutic use Atropine - therapeutic use c-Fos Cell Culture Techniques Child Child, Preschool Cohort Studies Comorbidity Cricetinae Disease Models, Animal Disease Progression Female Gene Expression Profiling Humans Incidence Infant Inflammation Inflammation - complications Inflammation - drug therapy Inflammation - epidemiology Interleukin 6 Male Myopia Myopia - diagnosis Myopia - epidemiology Myopia - etiology Myopia - pathology Nuclear factor κB Population Surveillance Research Paper Taiwan - epidemiology Tumor necrosis factor alpha
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Prevention and treatment of myopia is an important public problem worldwide. We found a higher incidence of myopia among patients with inflammatory diseases such as type 1 diabetes mellitus (7.9%), uveitis (3.7%), or systemic lupus erythematosus (3.5%) compared to those without inflammatory diseases (p
ISSN:	2352-3964 2352-3964
DOI:	10.1016/j.ebiom.2016.07.021